Politics of science: Progress toward prevention of the dementia-Alzheimer's syndrome

Zaven S. Khachaturian, Ara S. Khachaturian

Research output: Contribution to journalArticle

Abstract

There exist many challenges hampering the discovery and development of effective interventions to prevent dementia. Three major trends have now intersected to influence the emerging interest in disease modifying therapies that may delay or halt dementia. The three crucial factors shaping this current focus are: (1) the emergence of the longevity revolution and the impact of a aging society, (2) the effects of the US Federal investment in research in advancing knowledge about the neurobiology of aging and dementia, and (3) the problem of US legislators and health policy makers to balance the allocation of evermore scarce research funding resources. The purpose of this essay is to provide a survey of the politics of science and to describe efforts to correctly manage the high level of expectations of both the patient and research communities. The perspective offered reviews the history and evolution of the ideas to treat or prevent dementia and Alzheimer's disease as a national strategic goal. The aim is to evaluate the interplay between science and formulation of public policy for setting research priority. We use the history of developing US National Institute of Aging's extramural research programs on brain aging and Alzheimer's disease (Khachaturian, 2006; 2007) as an initial case study.

Original languageEnglish (US)
Pages (from-to)3-15
Number of pages13
JournalMolecular Aspects of Medicine
Volume43-44
DOIs
StatePublished - Jun 1 2015
Externally publishedYes

Fingerprint

Politics
Dementia
Alzheimer Disease
Aging of materials
Research
History
Neurobiology
Brain Diseases
Public Policy
Health Policy
Administrative Personnel
Brain
Health

Keywords

  • aging
  • Alzheimer
  • Alzheimer's Accountability Act
  • Appropriations
  • Congress
  • dementia
  • Funding
  • Health policy
  • National Alzheimer Project Act
  • National Institute of Aging
  • National Institutes of Health
  • National plan
  • Public policy
  • United States

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Molecular Medicine
  • Clinical Biochemistry
  • Medicine(all)

Cite this

Politics of science : Progress toward prevention of the dementia-Alzheimer's syndrome. / Khachaturian, Zaven S.; Khachaturian, Ara S.

In: Molecular Aspects of Medicine, Vol. 43-44, 01.06.2015, p. 3-15.

Research output: Contribution to journalArticle

Khachaturian, Zaven S. ; Khachaturian, Ara S. / Politics of science : Progress toward prevention of the dementia-Alzheimer's syndrome. In: Molecular Aspects of Medicine. 2015 ; Vol. 43-44. pp. 3-15.
@article{3e66d8f1a95543dc88ed8f9931206757,
title = "Politics of science: Progress toward prevention of the dementia-Alzheimer's syndrome",
abstract = "There exist many challenges hampering the discovery and development of effective interventions to prevent dementia. Three major trends have now intersected to influence the emerging interest in disease modifying therapies that may delay or halt dementia. The three crucial factors shaping this current focus are: (1) the emergence of the longevity revolution and the impact of a aging society, (2) the effects of the US Federal investment in research in advancing knowledge about the neurobiology of aging and dementia, and (3) the problem of US legislators and health policy makers to balance the allocation of evermore scarce research funding resources. The purpose of this essay is to provide a survey of the politics of science and to describe efforts to correctly manage the high level of expectations of both the patient and research communities. The perspective offered reviews the history and evolution of the ideas to treat or prevent dementia and Alzheimer's disease as a national strategic goal. The aim is to evaluate the interplay between science and formulation of public policy for setting research priority. We use the history of developing US National Institute of Aging's extramural research programs on brain aging and Alzheimer's disease (Khachaturian, 2006; 2007) as an initial case study.",
keywords = "aging, Alzheimer, Alzheimer's Accountability Act, Appropriations, Congress, dementia, Funding, Health policy, National Alzheimer Project Act, National Institute of Aging, National Institutes of Health, National plan, Public policy, United States",
author = "Khachaturian, {Zaven S.} and Khachaturian, {Ara S.}",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/j.mam.2015.06.001",
language = "English (US)",
volume = "43-44",
pages = "3--15",
journal = "Molecular Aspects of Medicine",
issn = "0098-2997",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Politics of science

T2 - Progress toward prevention of the dementia-Alzheimer's syndrome

AU - Khachaturian, Zaven S.

AU - Khachaturian, Ara S.

PY - 2015/6/1

Y1 - 2015/6/1

N2 - There exist many challenges hampering the discovery and development of effective interventions to prevent dementia. Three major trends have now intersected to influence the emerging interest in disease modifying therapies that may delay or halt dementia. The three crucial factors shaping this current focus are: (1) the emergence of the longevity revolution and the impact of a aging society, (2) the effects of the US Federal investment in research in advancing knowledge about the neurobiology of aging and dementia, and (3) the problem of US legislators and health policy makers to balance the allocation of evermore scarce research funding resources. The purpose of this essay is to provide a survey of the politics of science and to describe efforts to correctly manage the high level of expectations of both the patient and research communities. The perspective offered reviews the history and evolution of the ideas to treat or prevent dementia and Alzheimer's disease as a national strategic goal. The aim is to evaluate the interplay between science and formulation of public policy for setting research priority. We use the history of developing US National Institute of Aging's extramural research programs on brain aging and Alzheimer's disease (Khachaturian, 2006; 2007) as an initial case study.

AB - There exist many challenges hampering the discovery and development of effective interventions to prevent dementia. Three major trends have now intersected to influence the emerging interest in disease modifying therapies that may delay or halt dementia. The three crucial factors shaping this current focus are: (1) the emergence of the longevity revolution and the impact of a aging society, (2) the effects of the US Federal investment in research in advancing knowledge about the neurobiology of aging and dementia, and (3) the problem of US legislators and health policy makers to balance the allocation of evermore scarce research funding resources. The purpose of this essay is to provide a survey of the politics of science and to describe efforts to correctly manage the high level of expectations of both the patient and research communities. The perspective offered reviews the history and evolution of the ideas to treat or prevent dementia and Alzheimer's disease as a national strategic goal. The aim is to evaluate the interplay between science and formulation of public policy for setting research priority. We use the history of developing US National Institute of Aging's extramural research programs on brain aging and Alzheimer's disease (Khachaturian, 2006; 2007) as an initial case study.

KW - aging

KW - Alzheimer

KW - Alzheimer's Accountability Act

KW - Appropriations

KW - Congress

KW - dementia

KW - Funding

KW - Health policy

KW - National Alzheimer Project Act

KW - National Institute of Aging

KW - National Institutes of Health

KW - National plan

KW - Public policy

KW - United States

UR - http://www.scopus.com/inward/record.url?scp=84943448904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943448904&partnerID=8YFLogxK

U2 - 10.1016/j.mam.2015.06.001

DO - 10.1016/j.mam.2015.06.001

M3 - Article

C2 - 26054567

AN - SCOPUS:84943448904

VL - 43-44

SP - 3

EP - 15

JO - Molecular Aspects of Medicine

JF - Molecular Aspects of Medicine

SN - 0098-2997

ER -